Weight Loss Effect of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients with Obesity without Diabetes: a Systematic Review
Acta Endocrinologica (Bucharest) · 2022 · 18 (2) · 216-224
DOI: 10.4183/aeb.2022.216 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Endocrinologica (Bucharest), 2022. Verfasst von K G Pratama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rumah Sakit Ken Saras - General Medicine, Semarang. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rumah Sakit Ken Saras - General Medicine, Semarang.
- Atma Jaya Catholic University of Indonesia - Pluit Campus - Jakarta Indonesia.
Zitieren
APA
Pratama, K. G., Tandarto, K., & Hengky, A. (2022). Weight Loss Effect of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients with Obesity without Diabetes: a Systematic Review. Acta Endocrinologica (Bucharest), 18(2), 216-224. https://doi.org/10.4183/aeb.2022.216
Vancouver
Pratama KG, Tandarto K, Hengky A. Weight Loss Effect of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients with Obesity without Diabetes: a Systematic Review. Acta Endocrinologica (Bucharest). 2022;18(2):216-224. doi:10.4183/aeb.2022.216
BibTeX
@article{Pratama2022,
author = {Pratama, K G and Tandarto, K and Hengky, A},
title = {Weight Loss Effect of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients with Obesity without Diabetes: a Systematic Review},
journal = {Acta Endocrinologica (Bucharest)},
year = {2022},
volume = {18},
number = {2},
pages = {216--224},
doi = {10.4183/aeb.2022.216}
}
EUVIMED